Shelley L Deeks
Overview
Explore the profile of Shelley L Deeks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
1644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrar D, Bettinger J, Campigotto A, Deeks S, Drouin O, Embree J, et al.
Pediatr Res
. 2025 Jan;
PMID: 39856228
Background: Interpretations of pediatric COVID-19 severity are complicated by novel lineages and COVID-19 vaccine introduction. We estimated the risk of severe COVID-19 by SARS-CoV-2 lineage and vaccination status among hospitalized...
2.
Wright J, Crowcroft N, McLachlan E, Perez-Iratxeta C, Joh E, Osman S, et al.
PLoS One
. 2024 Aug;
19(8):e0309154.
PMID: 39159217
Introduction: The incidence of varicella in Canada has decreased by almost 99% since vaccination was introduced. However, variation in the timing and eligibility of vaccination programs across the country has...
3.
Alessandrini J, Cox J, de Pokomandy A, Hart T, Grace D, Grennan T, et al.
J Infect Dis
. 2024 Jul;
230(5):e1039-e1048.
PMID: 39041706
Background: Oral human papillomavirus (HPV) infections are a leading cause of oropharyngeal cancers. In 2015 and 2016, HPV vaccines became publicly funded for gay, bisexual, and other men who have...
4.
Grewal R, Hillier K, Deeks S, Yeung A, Wilson S, Wijayasri S, et al.
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae275.
PMID: 38868312
Background: New vaccine products were recently authorized for protection against invasive pneumococcal disease (IPD) in Canada. Our aim was to determine age- and serotype-specific trends in IPD incidence and severity...
5.
OBrien S, Deeks S, Hatchette T, Pambrun C, Drews S
J Assoc Med Microbiol Infect Dis Can
. 2024 Apr;
9(1):32-45.
PMID: 38567363
Background: SARS-CoV-2 seroprevalence monitors cumulative infection rates irrespective of case testing protocols. We aimed to describe Nova Scotia blood donor seroprevalence in relation to public health policy and reported data...
6.
Wright J, Science M, Osman S, Arnold C, Sumaida M, Crowcroft N, et al.
Vaccine
. 2023 Oct;
41(47):6895-6898.
PMID: 37845156
Introduction: Pertussis causes significant morbidity and mortality in infants aged <6 months. Maternal pertussis vaccination during pregnancy has been recommended in Canada since 2018 to reduce these negative outcomes. In...
7.
Buchan S, Chung H, To T, Daneman N, Guttmann A, Kwong J, et al.
J Pediatric Infect Dis Soc
. 2023 Jun;
12(7):421-430.
PMID: 37335754
Background: Respiratory syncytial virus (RSV) contributes significantly to morbidity in children, placing substantial burdens on health systems, thus RSV vaccine development and program implementation are a public health priority. More...
8.
Chambers C, Deeks S, Sutradhar R, Cox J, de Pokomandy A, Grennan T, et al.
Epidemiology
. 2023 Feb;
34(2):225-229.
PMID: 36722804
Background: Self-report of human papillomavirus (HPV) vaccination has ~80-90% sensitivity and ~75-85% specificity. We measured the effect of nondifferential exposure misclassification associated with self-reported vaccination on vaccine effectiveness (VE) estimates....
9.
Chambers C, Deeks S, Sutradhar R, Cox J, de Pokomandy A, Grennan T, et al.
J Infect Dis
. 2023 Jan;
228(1):89-100.
PMID: 36655513
Background: Real-world evidence of human papillomavirus (HPV) vaccine effectiveness (VE) against longitudinal outcomes is lacking among gay, bisexual, and other men who have sex with men (GBM). We compared 12-month...
10.
Chambers C, Deeks S, Sutradhar R, Cox J, de Pokomandy A, Grennan T, et al.
Vaccine
. 2022 May;
40(26):3690-3700.
PMID: 35577633
Background: Starting in 2015/16, most Canadian provinces introduced publicly-funded human papillomavirus (HPV) vaccination programs for gay, bisexual, and other men who have sex with men (GBM) aged ≤ 26 years....